Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
UPI > SEC Filings for UPI > Form 8-K on 2-Jun-2014All Recent SEC Filings

Show all filings for UROPLASTY INC



Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 29, 2014, the Board of Directors of Uroplasty, Inc. appointed Kevin H. Roche (63) to serve as a Class I director until Uroplasty's next annual meeting of shareholders. Mr. Roche will chair Uroplasty's Nominating Committee and also serve as a member of its Audit Committee. Mr. Roche will be compensated for his services on the board in the same fashion as other independent board members.

Mr. Roche's background includes more than 30 years in legal, advisory, and executive operating roles within the healthcare industry. He previously served as the General Counsel of UnitedHealth Group, later becoming CEO of their Ingenix division. He currently leads Roche Consulting, LLC, a general health care consulting and investing firm providing strategic, operational, legal and other business advice to industry clients. Mr. Roche also served as managing partner at Vita Advisors LLC, a healthcare mergers and acquisition advisory firm. Mr. Roche earned his law degree from the University of Minnesota Law School and received his M.B.A. from the University of Minnesota's Carlson School of Business.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release dated June 2, 2014 (filed herewith)

  Add UPI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for UPI - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.